Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-11 Sale |
2021-03-15 6:22 pm |
FIBROGEN INC | FGEN | KEARNS THOMAS F JR Director |
18,000 | $35.02 | $630,360 | 258,164 (Indirect Direct) |
View |
| 2021-02-17 Sale |
2021-02-19 7:10 pm |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $52.4 | $314,383 | 39,100 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 7:24 pm |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $43.38 | $260,280 | 33,100 (Direct) |
View |
| 2021-01-14 Sale |
2021-01-15 8:02 pm |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
5,999 | $40.04 | $240,200 | 39,100 (Direct) |
View |
| 2020-12-28 Sale |
2020-12-30 6:07 pm |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,001 | $40.4 | $242,455 | 45,099 (Direct) |
View |
| 2020-12-16 Sale |
2020-12-17 7:06 pm |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
3,350 | $41.61 | $139,394 | 192,292 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-17 7:04 pm |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
3,068 | $43.6 | $133,765 | 266,144 (Direct) |
View |
| 2020-09-16 Sale |
2020-09-18 5:19 pm |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
3,351 | $44.01 | $147,478 | 198,934 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 6:03 pm |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
3,070 | $43.63 | $133,944 | 272,226 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-07 Tax Withholding |
2021-06-09 7:26 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
2,030 | $22.9 | 165,251 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:09 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Schoeneck James A Director |
12,500 | $0 | 93,322 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:08 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | RIGGS RORY B Director |
12,500 | $0 | 1,009,263 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:07 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Lema Gerald Director |
12,500 | $0 | 29,100 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:07 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
12,500 | $0 | 45,600 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:06 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | KEARNS THOMAS F JR Director |
12,500 | $0 | 270,664 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:05 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Ho Maykin Director |
12,500 | $0 | 23,755 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:05 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Henderson Jeffrey William Director |
12,500 | $0 | 25,600 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:04 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | EDWARDS JEFFREY L Director |
12,500 | $0 | 25,600 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:02 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Cravatt Benjamin Director |
12,500 | $0 | 16,414 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:01 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
12,500 | $0 | 16,414 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:00 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Blaug Suzanne Director |
12,500 | $0 | 21,848 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 6:22 pm |
N/A N/A |
FIBROGEN INC | FGEN | KEARNS THOMAS F JR Director |
18,000 | $3.5 | 258,164 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 6:22 pm |
N/A 2021-03-15 |
FIBROGEN INC | FGEN | KEARNS THOMAS F JR Director |
18,000 | $0 | 258,164 (Direct) |
View |
| 2021-03-08 Tax Withholding |
2021-03-10 5:38 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
5,221 | $33.37 | 147,346 (Direct) |
View |
| 2021-03-08 Tax Withholding |
2021-03-10 5:34 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
5,657 | $33.37 | 282,187 (Direct) |
View |
| 2021-03-08 Tax Withholding |
2021-03-10 5:32 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
5,679 | $33.37 | 166,597 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 7:28 pm |
N/A 2031-02-24 |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
48,600 | $0 | 79,250 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 7:25 pm |
N/A 2031-02-24 |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
60,700 | $0 | 192,467 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 7:23 pm |
N/A 2031-02-24 |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
63,400 | $0 | 329,544 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 7:21 pm |
N/A 2031-02-24 |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
63,400 | $0 | 213,976 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 7:19 pm |
N/A 2031-02-24 |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
246,000 | $0 | 329,073 (Direct) |
View |
Ownership(A) |
2021-02-26 7:07 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
0 | $0 | 650 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:10 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $28.65 | 39,100 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-19 7:10 pm |
N/A 2027-06-07 |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $0 | 39,100 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 7:24 pm |
N/A 2026-06-08 |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $0 | 33,100 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 7:24 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $19.05 | 33,100 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-15 8:02 pm |
N/A 2026-06-08 |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
5,999 | $0 | 39,100 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-15 8:02 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
5,999 | $19.05 | 39,100 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 7:40 pm |
N/A N/A |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
5,411 | $38.31 | 83,073 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 7:08 pm |
N/A 2023-04-17 |
FIBROGEN INC | FGEN | Schoeneck James A Director |
6,000 | $0 | 80,822 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 7:08 pm |
N/A N/A |
FIBROGEN INC | FGEN | Schoeneck James A Director |
6,000 | $9.775 | 80,822 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 6:07 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,000 | $18.34 | 45,099 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 6:07 pm |
N/A 2025-06-03 |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
6,001 | $0 | 45,099 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 6:07 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kurkijarvi Kalevi Director |
1 | $19.05 | 45,099 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-09 7:34 pm |
N/A N/A |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
3,292 | $41.99 | 195,642 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-09 7:33 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
2,728 | $41.99 | 131,767 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-09 7:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
3,014 | $41.99 | 269,212 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-09 7:27 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
3,039 | $41.99 | 150,576 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 6:51 pm |
N/A 2030-12-01 |
FIBROGEN INC | FGEN | Eisner Mark Incoming Chief Medical Officer |
115,000 | $0 | 115,000 (Direct) |
View |
Ownership |
2020-12-03 6:41 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Incoming Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 4:52 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
7,082 | $14.57 | 134,495 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 4:52 pm |
N/A 2024-03-19 |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
7,082 | $0 | 134,495 (Direct) |
View |
| 2020-09-08 Tax Withholding |
2020-09-10 7:36 pm |
N/A N/A |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
3,291 | $42.16 | 202,285 (Direct) |
View |